| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 05/23/2007 | CN1966525A Human monoclonal antibodies to epidermal growth factor receptor (egfr) |
| 05/23/2007 | CN1966524A Novel monoclonal antibody and nematode larval antigens |
| 05/23/2007 | CN1966081A Bivalent DNA vaccine for Japanese blood fluke and preparation process thereof |
| 05/23/2007 | CN1966079A Immunoglobulin for resisting O and Asia I type foot and mouth disease used for cow and pig |
| 05/23/2007 | CN1966078A Therapeutic vaccine composition for hepatitis B |
| 05/23/2007 | CN1966077A Orally administered vaccine of hepatitis E and preparation process thereof |
| 05/23/2007 | CN1966076A Mass-production method of hydrophobic vaccine |
| 05/23/2007 | CN1966075A Method for preparing inactivated vaccine of encephalitis B used for human being |
| 05/23/2007 | CN1966074A Combined vaccine for anthrax and black death |
| 05/23/2007 | CN1965665A Method for preparing immune milk or milk powder containing IgY antibody |
| 05/23/2007 | CN1317304C Fusion protein, gene encoding same, and expression method and use thereof |
| 05/23/2007 | CN1317303C Anti-human tenascin monoclonal antibody |
| 05/23/2007 | CN1317301C Modulation of IL-2-and IL-15-mediated T cell responses |
| 05/23/2007 | CN1317034C Nuclec acid adjuvants |
| 05/22/2007 | US7220839 Useful for separating proliferative hepatocytes from a human hepatocyte population |
| 05/22/2007 | US7220829 Cytokine binding domain of cytokine receptors |
| 05/22/2007 | US7220826 HIV immunogen; DNA vaccines; amino acid sequences |
| 05/22/2007 | US7220728 Administering by topical or lavage administration to mucosal tissue nucleic acid molecule that comprises a nucleotide sequence that either encodes a desired peptide or protein |
| 05/22/2007 | US7220722 Lipoprotein-regulating medicants |
| 05/22/2007 | US7220717 Administering formulation comprising polypeptide and muteins; For immunoregulation and/or treatment of inflammation; muteins, |
| 05/22/2007 | US7220559 Development of human monoclonal antibodies and uses thereof |
| 05/22/2007 | US7220552 conjugates of a target protein ligand and a blocking protein ligand, optionally joined by a linking group; bifunctional inhibitor molecule simultaneously binds to its corresponding target and blocking proteins to produce a tripartite complex that inhibits protein protein interaction |
| 05/22/2007 | US7220551 Vaccine containing human papillomarus virus antigen, aluminum hydroxide and a preferential stimulator of TH1 cell response such as 3 De-O-acylated monophosphoryl lipid A (3D-MPL) |
| 05/22/2007 | US7220545 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method |
| 05/22/2007 | US7220423 Using a genetic vaccine that codes for conserved domains 2, 3 and 5 of a major outer membrane protein (MOMP) of a strain of Chlamydia; protection against lung infections from the strain of Chlamydia trachomatis for example |
| 05/22/2007 | US7220422 In situ adminiatering Clostridium toxin; antiinflammatory agents |
| 05/22/2007 | US7220421 Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections |
| 05/22/2007 | US7220420 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 05/22/2007 | US7220419 Self-assembling recombinant papillomavirus capsid proteins |
| 05/22/2007 | US7220418 Delivery of trefoil peptides |
| 05/22/2007 | US7220415 Vaccine composition |
| 05/22/2007 | US7220414 For use in pharmaceutical and biomedical applications, stability; conjugates of polymers with drugs anticancer drugs used in cancer therapy |
| 05/22/2007 | US7220413 Administering as wound healing or antiscarring agent for skin; surgery, injuries, fibrosis |
| 05/22/2007 | US7220412 Method of preparing an undifferentiated cell |
| 05/22/2007 | US7220410 Angiogenesis inhibitors; inhibits growth of a human tumor xenograft in a mouse; cell lines; anticarcinogenic agents |
| 05/22/2007 | US7220409 Stabilization of immunoglobulins at low pH |
| 05/22/2007 | US7220399 Alpha or beta emitters attached to fragments in radioimmunotherapy |
| 05/22/2007 | CA2320040C Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
| 05/22/2007 | CA2237983C Non-invasive localization of a light-emitting conjugate in a mammal |
| 05/22/2007 | CA2217882C European vaccine strains of the porcine reproductive and respiratory syndrome virus (prrsv) |
| 05/22/2007 | CA2182274C Antigenic preparation for treatment or prevention of helicobacter infection |
| 05/22/2007 | CA2143187C Anti-feline immunodeficiency virus (fiv) vaccines |
| 05/22/2007 | CA2111645C Fibrinogen fragment e peptides and antibodies thereto |
| 05/22/2007 | CA2110518C Ctla4 receptor, fusion proteins containing it and uses thereof |
| 05/22/2007 | CA2100559C Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 05/22/2007 | CA2073045C A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 05/18/2007 | WO2007056642A2 Method for modulating inflammatory responses |
| 05/18/2007 | WO2007056578A1 Immunomodulatory properties of multipotent adult progenitor cells and uses thereof |
| 05/18/2007 | WO2007056540A2 Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy |
| 05/18/2007 | WO2007056539A2 Prophylaxis and treatment of enterocolitis associated with anti-ctla-4 antibody therapy |
| 05/18/2007 | WO2007056536A1 Glioma-specific antibodies against behab/brevican for diagnostic and therapeutic applications |
| 05/18/2007 | WO2007056525A2 High affinity siglec ligands |
| 05/18/2007 | WO2007056511A2 Metal-binding therapeutic peptides |
| 05/18/2007 | WO2007056352A2 Compositions and methods for controlling tissue factor signaling specificity |
| 05/18/2007 | WO2007056301A2 Antibody therapy for treatment of diseases associated with gluten intolerance |
| 05/18/2007 | WO2007056266A2 Cd40 ligand fusion protein vaccine |
| 05/18/2007 | WO2007056227A2 Use of complement pathway inhibitors to treat ocular diseases |
| 05/18/2007 | WO2007056118A1 Antineoplastic combinations with mtor inhibitor, herceptin, and/or hki-272 |
| 05/18/2007 | WO2007056061A2 Concurrent chemotherapy and immunotherapy |
| 05/18/2007 | WO2007056039A2 Therapies for seizure disorders using rlip76 |
| 05/18/2007 | WO2007055982A2 Therapies for the regulation of insulin and glucose using rlip76 |
| 05/18/2007 | WO2007055966A2 Therapies for cancer using rlip76 |
| 05/18/2007 | WO2007055902A1 Immunogenic peptides and methods of use for treating and preventing cancer |
| 05/18/2007 | WO2007055684A2 Determining security realm identity before permitting network connection |
| 05/18/2007 | WO2007055437A1 Killed lactic acid bacteria preparation having enhanced immunity and method for preparing the same |
| 05/18/2007 | WO2007055378A1 Method for treatment or prevention of disease associated with functional disorder of regulatory t cell |
| 05/18/2007 | WO2007054820A2 Manufacture of vaccines that contain both hepatitis b virus surface antigen and surfactant |
| 05/18/2007 | WO2007054788A1 Expression system incorporating a capsid promotor sequence as an enhancer of a cytomegalovirus promotor |
| 05/18/2007 | WO2007054537A1 Novel bacterium and vaccine |
| 05/18/2007 | WO2007054348A1 Novel medicaments |
| 05/18/2007 | WO2007054183A1 Reduction of restenosis |
| 05/18/2007 | WO2007054120A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies |
| 05/18/2007 | WO2007054090A1 Therapeutic vaccines targeting hmgb1 |
| 05/18/2007 | WO2007053956A1 Cancer antigen mage-a9 and uses thereof |
| 05/18/2007 | WO2007053899A1 Differentiating therapeutic composition |
| 05/18/2007 | WO2007033140A3 Prok2 antagonists and methods of use |
| 05/18/2007 | WO2007031334A3 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants |
| 05/18/2007 | WO2007030637A9 Hiv gp120 crystal structure and its use to identify immunogens |
| 05/18/2007 | WO2007019865A3 Therapy with cd4 binding peptides and radiation |
| 05/18/2007 | WO2007008072A3 CROSS-ß STRUCTURE BINDING COMPOUNDS |
| 05/18/2007 | WO2007007160A3 Anti-madcam antibodies to treat fever |
| 05/18/2007 | WO2007007151A3 Use of anti-mad-cam antibody for the treatment of emphysema |
| 05/18/2007 | WO2007007086A3 Antibodies for anthrax |
| 05/18/2007 | WO2006132907A3 Methods of treating, diagnosing or detecting cancer using an ephb3 modulator |
| 05/18/2007 | WO2006127823A3 Silicibacter sp. strain useful for genetic transformation of marine algae and production of antibiotic agents |
| 05/18/2007 | WO2006119395A3 Combination of a beta-glucan and an egf receptor antagonist for the treatment of cancer and infection |
| 05/18/2007 | WO2006116657A3 Single-chain antibody with cleavable linker |
| 05/18/2007 | WO2006081323A3 Anti-cancer dna vaccine employing plasmids encoding mutant oncoprotein antigen and calreticulin |
| 05/18/2007 | WO2006078164A8 Mycobacteria with mannose cap-deficient lipoarabinomannan |
| 05/18/2007 | WO2006015775A3 Egfr kinase inhibitor combinations for treating respiratory and gastrointestinal disorders |
| 05/18/2007 | WO2005120565A3 Sars vaccines and methods to produce highly potent antibodies |
| 05/18/2007 | WO2005111066A8 Polypeptides from non-typeable haemophilus influenzae |
| 05/18/2007 | WO2005072126A3 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 05/18/2007 | CA2633768A1 Reduction of restenosis |
| 05/18/2007 | CA2630023A1 Cancer antigen mage-a9 and uses thereof |
| 05/18/2007 | CA2629125A1 Glioma-specific antibodies against behab/brevican for diagnostic and therapeutic applications |
| 05/18/2007 | CA2628860A1 Manufacture of vaccines that contain both hepatitis b virus surface antigen and surfactant |
| 05/18/2007 | CA2628552A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies |
| 05/18/2007 | CA2628546A1 Therapeutic vaccines targeting hmgb1 |
| 05/18/2007 | CA2628315A1 Compositions and methods for the detection of trypanosoma cruzi infection |